Company Filing History:
Years Active: 1976
Title: W D Tigertt: Innovator in Gentamicin Assay Technology
Introduction: W D Tigertt, based in Baltimore, MD, is an accomplished inventor known for his significant contributions to medical diagnostics, particularly through the development of an innovative assay for gentamicin in blood. His work has important implications for patient care, especially for those receiving gentamicin treatment.
Latest Patents: W D Tigertt holds a patent for an assay that utilizes the ability of gentamicin to inhibit urease synthesis in a gentamicin-susceptible microorganism. This method is designed to accurately measure the concentration of gentamicin in a patient's blood, providing a crucial tool for healthcare practitioners. The assay operates by comparing the amount of C^14 O2 produced from blood samples with known concentrations of gentamicin, allowing for precise monitoring of therapeutic levels in patients.
Career Highlights: Throughout his career, W D Tigertt has made notable advancements in the field of medical diagnostics while working at Johnston Laboratories, Inc. His innovative approach to developing assay technologies demonstrates his commitment to enhancing patient treatment protocols through scientific research and application.
Collaborations: At Johnston Laboratories, Inc., W D Tigertt has collaborated with esteemed researcher Gardner Middlebrook. Together, they have furthered the exploration and application of methodologies related to microbial interactions and antibiotic monitoring, contributing valuable insights to the field.
Conclusion: W D Tigertt's pioneering work in the assay of gentamicin highlights the vital role of inventors in advancing medical science. His patent not only exemplifies the intersection of innovation and healthcare but also sets a precedent for continued research and improvements in diagnostic methodologies.